Sevoflurane protects against acute kidney injury in a small-size liver transplantation model

American Journal of Nephrology

Volumn 32, Issue 4, 2010, Pages 347-355

  Kong, H Y ^a   Zhu, S M ^a   Wang, L Q ^a   He, Y ^a   Xie, H Y ^a   Zheng, S S ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute kidney injury; Liver transplantation; Sevoflurane

Indexed keywords

CHLORAL HYDRATE; FLUORIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GRAFT SURVIVAL; HEMODYNAMICS; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; LIVER FUNCTION; LIVER GRAFT; LIVER SIZE; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; URINE LEVEL;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANESTHETICS, INHALATION; ANIMALS; CREATININE; FLUORIDES; INTERLEUKIN-6; KIDNEY; LIPOCALINS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; METHYL ETHERS; MODELS, ANIMAL; NF-KAPPA B; PEROXIDASE; PROTO-ONCOGENE PROTEINS; RATS; REPERFUSION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956072164     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319623     Document Type: Article

References (30)

1. Smith JO, Shiffman ML, Behnke M, Stravitz RT, et al: Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. Liver Transpl 2009; 15:273-279.
2. Davis CL: Kidney failure in liver transplantation: it is time for action. Am J Transplant 2006; 6:2533-2534.
3. Barri YM, Sanchez EQ, Jennings LW, Melton LB, et al: Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl 2009; 15: 475-483.
4. Cabezuelo JB, Ramirez P, Rios A, et al: Risk factors of acute renal failure after liver transplantation. Kidney Int 2006; 69:1073-1080.
5. Yamamoto S, Sato Y, Ichida T, et al: Acute renal failure during the early postoperative period in adult living-related donor liver transplantation. Hepatogastroenterology 2004; 51: 1815-1819. (Pubitemid 39389787)
6. Lee SK, Park JB, Kim SJ, et al: Early postoperative renal dysfunction in the adult living donor liver transplantation. Transplant Proc 2007; 39:1517-1519.
7. Chibber A, Dziak J, Kolano J, Norton JR, Lustik S: Anesthesia care for adult live donor hepatectomy: our experiences with 100 cases. Liver Transpl 2007; 13: 537-542.
8. Shayevitz JR, Rodriguez JL, Gilligan L, Johnson KJ, Tait AR: Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome. Shock 1995; 4:61-67.
9. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfu-sion injury in vivo. Anesthesiology 2004; 101: 1313-1324.
10. Lee HT, Kim M, Jan M, Emala CW: Anti-inflammatory and anti-necrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol 2006; 291:F67-F78.
11. Conzen PF, Kharasch ED, Czerner SF, Artru AA, Reichle FM, Michalowski P, et al: Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97: 578-584.
12. Gentz BA, Malan TP Jr: Renal toxicity with sevof lurane: a storm in a teacup? Drugs 2001; 61:2155-2162.
13. Holaday DA, Smith FR: Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981; 54:100-106.
14. Kharasch ED, Thummel KE: Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 1993; 79: 795-807.
15. Kharasch ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevo-flurane metabolism. Intrarenal fluoride production as a possible mechanism of met hox yf lura ne nephrotoxicit y. Anest hesiology 1995; 82: 689-699.
16. Van Obbergh LJ, Verbeeck RK, Michel I, et al: Extrahepatic metabolism of sevoflurane in children undergoing orthotopic liver transplantation. Anesthesiology 2000; 92: 683-686.
17. Kanbak M, Karagoz AH, Erdem N, et al: Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations. Transplant Proc 2007; 39:1544-1548.
18. Man K, Lee TK, Liang TB, et al: FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. Ann Surg 2004; 240: 159-168.
19. Man K, Lo CM, Ng IO, Wong YC, Qin LF, Fan ST, Wong J: Liver transplantation in rats using small-for-size grafts: a study of hemo-dynamic and morphological changes. Arch Surg 2001; 136: 280-285.
20. Bellamy MC, Galley HF, Webster NR: Changes in inflammatory mediators during orthotopic liver transplantation. Br J An-aest h 1997; 79: 33 8-3 41.
21. Park Y, Hirose R, Dang K, Xu F, et al: Increased severity of renal ischemia reperfu-sion injury with venous clamping compared to arterial clamping in a rat model. Surgery 2008; 143:243-251.
22. Parikh CR, Devarajan P: New biomarkers of acute kidney injury. Crit Care Med 2008; 36:S159-S165. (Pubitemid 351483046)
23. Mori K, Nakao K: Neutrophil gelatinase-as-sociated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007; 71: 967-970.
24. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, et al: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6:1639-1645.
25. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HAT: Association between increases in urinary neutrophil gelati-nase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. An-esthesiology 2006; 105:485-491.
26. Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, Feiner J: Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associ-ated lipocalin. Liver Transpl 2009; 15: 1852-1860.
27. Mutoh T, Nishimura R, Kim HY, Matsunaga S, Sasaki N: Cardiopulmonary effects of sevoflurane, compared with halothane, en-flurane, and isoflurane, in dogs. Am J Vet Res 1997; 58: 885-890.
28. Heerdt PM, Pleimann BE: The dose-dependent effects of halothane on right ventricular contraction pattern and regional inotropy in swine. Anesth Analg 1996; 82: 1152-1158.
29. Higuchi H, Sumikura H, Sumita S, et al: Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 19 95; 83: 443-445.
30. Shimada H, K iyozu m i M, Kojima S: Effect of N-benzyl-Dglucamine dithiocarbamate on renal toxicity of inorganic mercury in rats. Chem Pharm Bull 1990; 38:1429-1431. (Pubitemid 20290854)